ANI Pharmaceuticals, Inc. Aktie News
80,25 €
0,68 %
gestern
L&S,
28. Oktober, 22:53 Uhr
Index
Industrie
tracken
ANI Pharmaceuticals, Inc. Aktie News
Positiv
Seeking Alpha
●
etwa 4 Stunden alt
In my opinion, ANI Pharmaceuticals should beat earnings and revenue estimates for the 13th consecutive quarter. Purified Cortrophin sales should lead the way. ANIP should announce approval and marketing of two new drugs, Inzirqo and Tezruly. Updated sales from Purified Cortophin Gel, Inzirqo and Tezruly could result in ANIP raising 2025 guidance for the 3rd time this year, in my view.
Neutral
GlobeNewsWire
●
5 Tage alt
PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its third quarter 2025 financial results on Friday, November 7, 2025, prior to the market open.
Positiv
Investors Business Daily
●
6 Tage alt
This leading rare disease drug stock is setting up in a flat base. The drugmaker beat earnings estimates by 28% last quarter.
Neutral
GlobeNewsWire
●
13 Tage alt
Presentation at AAO 2025 part of ongoing NEW DAY data dissemination at medical meetings Presentation at AAO 2025 part of ongoing NEW DAY data dissemination at medical meetings
Neutral
Seeking Alpha
●
etwa 2 Monate alt
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:50 PM EDT Company Participants Nikhil Lalwani - President, CEO & Director Conference Call Participants Daniel Cohen - Morgan Stanley Presentation Daniel Cohen Okay. Good Afternoon, everybody.
Neutral
GlobeNewsWire
●
2 Monate alt
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company's executive leadership team will present at two upcoming investor conferences as follows:
Neutral
Seeking Alpha
●
3 Monate alt
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Christopher K. Mutz - Senior VP & Head of Rare Disease Nikhil Lalwani - President, CEO & Director Stephen P.
Neutral
GlobeNewsWire
●
3 Monate alt
BAUDETTE, Minn., Aug. 08, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the second quarter ended June 30, 2025.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
